期刊文献+

HBV血清标志物e抗原假阴性的原因分析及对策 被引量:3

Cause of HBeAg false-negative reaction and it countermeasures
暂未订购
导出
摘要 目的:分析ELISA法检测乙型肝炎病毒(HBV)标志物e抗原(HBeAg)出现假阴性的原因并探讨应对措施,防止HBeAg阳性漏检。方法:凡用ELISA法检测的HBV标志物5项指标结果为表面抗原(HBsAg)和核心抗体(抗-HBc)阳性(俗称1、5阳性)而HBeAg为阴性的,应用4家试剂2种方法联合复检HBeAg确认结果。具体措施:(1)对每天用A试剂检测的HBV标志物5项指标测得结果仅1、5阳性的样品,用A、B、C试剂(ELISA法)联合复检HBeAg。(2)无论A、B、C哪种试剂,只要HBeAg复检结果为阳性、弱阳性或样品测定D值在灰区范围的,必须用D试剂(化学发光法)进一步复检确认阳性,以D试剂复检结果为最终确认结果。结果:274份样品用A、B、C试剂复检HBeAg(室内质控值在控),A试剂结果仍然全部阴性,阳性漏检率为2.18%,B试剂结果5例阳性,阳性漏检率为0.36%,C试剂结果6例阳性(5例阳性与B试剂复检样品号码相同,1例A、B试剂复检为阴性C试剂复检为阳性),无阳性漏检。复检6例HBeAg阳性的样品用D试剂复检确认仍为阳性,无阳性漏检。结论:ELISA法A、B试剂存在比例不等的HBeAg假阴性。在日常工作中,对ELISA法测定的HBV标志物5项指标仅1、5阳性的样品结果,严格多家试剂联合复检HBeAg是非常必要的。 Objective:To analyze the cause of HBeAg (one of HBV markers) false-negative reaction during ELISA examination and to discuss its countermeasures. Methods: The patients who were HBsAg (+) , HBcAb (+) and HBeAg (-) by ELISA examination were further detected with the reagents of 4 different manufacturers in 2 steps: (1) The serum samples positive of HBsAg and HBcAb by ELISA using reagent A were further detected by qualitative analysis and Double-antibody sandwich ELISA using reagent A , B and C. (2) Reagent D (chemiluminescence method) was used to confirm the diagnosis if the results were positive or weakly positive of HBeAg, or the D values were within a specific range by ELISA using reagent A, B or C. The result of reagent D was taken as the final result. Results: The 274 sera negative of HBeAg were still negative when using reagent A, with the false-negative rate being 2.18%; 5 sera were positive when using reagent B, with false-negative rate being 0.36% ; and 6 sera (including the 5 positive ones using reagent B and 1 negative case using reagent A and B) were positive when using reagent C, without false-negative case. All the 6 positive samples were confirmed by chemiluminescence using reagent D. Conclusion: It is suggested that ELISA examination using reagent A or B can lead to false-negative results of HBeAg. HBsAg (+), HBcAb (+) and HBeAg (-) sera in ELISA examination should be examined with combinations of reagents of different manufacturers.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2006年第7期768-770,共3页 Academic Journal of Second Military Medical University
关键词 肝炎病毒 乙型 HBEAG 假阴性反应 酶联免疫吸附测定 化学发光测定法 hepatitis B virus HBeAg false-negaitive reactions enzyme-linked immunosorbent assay chemiluminescent
  • 相关文献

参考文献2

二级参考文献30

  • 1Source: Centers for Disease Control and Prevention, http ://www. cdc. gov/ncidod/diseases/hepatitis/slideset/hep_b/hep_b, pdf.
  • 2Locarnini SA. Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance. Hepatology, 1998,27:294 -297.
  • 3Jongerius JM, Wester M, Cuypers HT, et al. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion, 1998 ,38:56-59.
  • 4Seddigh-Tonekaboni S, Lim WL, Young B, et al. Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient.J Viral Hepat, 2001,8 : 154-158.
  • 5Grethe S, Monazahian M, Bohme I, et al. Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigennegative subject. J Virol, 1998,72:7692-7696.
  • 6Book CT, Tillmann HL, Torresi J,et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology,2002 , 122:264-273.
  • 7Pult I, Chouard T, Wieland S, et al. A hepatitis B virus mutant with a new hepatceyte nuclear factor 1 binding site emerging in transplant-transmitted fulminant hepatitis B. Hepatology, 1997,25 : 1507-1515.
  • 8Hunt CM, McGill JM, Allen MI, et al. Clinical relevance of hepatitis B viral mutations. Hepatology,2000,31 : 1037-1044.
  • 9Oon C J, Lim GK, Ye Z, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine, 1995,13:699-702.
  • 10Terrauh NA, Zhou S, McCory RW, et al. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology, 1998,28:555-561.

共引文献15

同被引文献7

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部